Actively Recruiting
HRQOL in Thyroid Cancer and Thyroid Tumours
Led by Oslo University Hospital · Updated on 2022-03-11
200
Participants Needed
1
Research Sites
531 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Most patients with thyroid cancer have a long life expectancy, and it has been assumed among health professionals that therefore the quality of life (QOL) is good. Some European studies have shown that the quality of life among thyroid cancers is worse than the general population, and almost as low as other cancer diagnoses, with a worse prognosis and a more burdening treatment. Aim: To examine prospectively the quality of life in participants undergoing diagnostic thyroid surgery and participants undergoing surgery for certain thyroid cancer. By examining both groups we wish to find answers if quality of life is affected, and if so - mostly affected by the diagnosis or the surgery itself. Methods: Participants enroll the study after informed consent, and quality of life will be assessed using quality of life questionnaires EORTC QLQ C30, EORTC THY 47 and EORTC FA12 before surgery, and 6 and 12 months after surgery. This study will form two main groups of participants; with and without thyroid cancer.
CONDITIONS
Official Title
HRQOL in Thyroid Cancer and Thyroid Tumours
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Planned hemi- or total thyroidectomy at the ENT Department of Oslo University Hospital
- Thyroid tumor with fine needle aspiration results of Bethesda 3-6 or other clinical signs suspicious of cancer
- Ability to understand and complete questionnaires
- Provided informed consent to participate
You will not qualify if you...
- Unable to complete or understand questionnaires
- Age below 18 years
- Thyroid surgery within the last 2 years
- Thyroid surgery for reasons other than those listed above
- Participants who had postoperative external radiotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ENT department, Oslo University Hospital
Oslo, Norway
Actively Recruiting
Research Team
B
Bianca MR Lorntzsen, MD
CONTACT
T
Terje A Osnes, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here